# Biomarkers of Renal Dysfunction in Neuroblastoma Survivors

> **NCT03947346** · — · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 28 (actual)

## Conditions studied

- Neuroblastoma Survivors

## Interventions

- **OTHER:** Urine sample

## Key facts

- **NCT ID:** NCT03947346
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-09
- **Primary completion:** 2025-07-15
- **Final completion:** 2025-07-15
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2025-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03947346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03947346, "Biomarkers of Renal Dysfunction in Neuroblastoma Survivors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03947346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*